Pharmacokinetics of Advantage Arrest
Recruiting in Palo Alto (17 mi)
PM
Overseen byPeter Milgrom, DDS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Advantage Silver Dental Arrest, LLC
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?
The study aim is to characterize the kinetics of silver and fluoride after topical application of silver diamine fluoride.
Research Team
PM
Peter Milgrom, DDS
Principal Investigator
University of Washington
Eligibility Criteria
Inclusion Criteria
18 years or older, minimum 20 teeth, healthy, not taking prescription or OTC medications
Treatment Details
Interventions
- 38% silver diamine fluoride (Anti-caries agent)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: 38% silver diamine fluorideExperimental Treatment1 Intervention
38% silver diamine fluoride, topical, 1 drop, single application
Find a Clinic Near You
Who Is Running the Clinical Trial?
Advantage Silver Dental Arrest, LLC
Lead Sponsor
Trials
6
Recruited
620+
University of Washington
Collaborator
Trials
1,858
Recruited
2,023,000+
Dr. Timothy H. Dellit
University of Washington
Chief Executive Officer since 2023
MD from University of Washington
Dr. Anneliese Schleyer
University of Washington
Chief Medical Officer since 2023
MD, MHA